ask="5.00"
ask_size="100"
average_daily_volume="146388"
bid="4.57"
bid_size="600"
book_value="2.54"
change="-0.16"
change_from_200_day_moving_average="-0.32"
change_from_50_day_moving_average="0.45"
change_from_52_week_high="-6.86"
change_From_52_week_low="0.97"
change_in_percent="-3.27%"
close="4.73"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.51"
ebitda="-74.76M"
eps_estimate_current_year="-1.08"
eps_estimate_next_quarter="-0.28"
eps_estimate_next_year="-1.12"
ex_dividend_date="N/A"
float_shares="24544000"
high="5.02"
high_52_weeks="11.59"
last_trade_date="3/14/2017"
last_trade_price="4.73"
last_trade_size="3255"
last_trade_time="4:00pm"
low="4.51"
low_52_weeks="3.76"
market_capitalization="334.81M"
moving_average_200_day="5.05"
moving_average_50_day="4.28"
name="Adaptimmune Therapeutics plc"
notes="N/A"
one_year_target_price="14.33"
open="5.02"
pe_ratio="N/A"
peg_ratio="0.11"
percent_change_from_200_day_moving_average="-6.25%"
percent_change_from_50_day_moving_average="+10.46%"
percent_change_from_52_week_high="-59.18%"
percent_change_from_52_week_low="+25.80%"
previous_close="4.89"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.92"
price_per_sales="36.34"
revenue="9.52M"
shares_outstanding="70785000"
short_ratio="4.56"
stock_exchange="NMS"
symbol="ADAP"
volume="383770"
weeks_range_52="3.76 - 11.59"
